Connacht Asset Management LP Astrazeneca PLC Transaction History

Connacht Asset Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $578,769 - $656,214	-9,165 Reduced 62.59%	5,478 $380,000
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $134,657 - $174,972	-2,484 Reduced 14.5%	14,643 $992,000
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $306,879 - $785,721	-5,788 Reduced 25.26%	17,127 $939,000
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $1.36 Million - $1.63 Million	22,915 New	22,915 $1.51 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Connacht Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Connacht Asset Management LP with notifications on news.